Literature DB >> 11045386

Penicillamine induced lupus-like syndrome: a case report.

H C Lin1, K C Hwang, H J Lee, M J Tsai, Y H Ni, B L Chiang.   

Abstract

Several drugs have been suggested to cause lupus-like syndrome. However, penicillamine-induced lupus-like syndrome has only rarely been reported in patients with Wilson's disease. We describe a 6- year-old Taiwanese girl, with a diagnosis of Wilson's disease in November, 1997, who developed lupus-like syndrome 17 months after penicillamine treatment. After treatment with prednisolone and decrease in the dose of penicillamine, her symptoms subsided gradually. This is the first such case reported in a Taiwanese patient. Because the symptoms of drug-induced lupus (DIL) are nonspecific, subjective and variable, the diagnosis of DIL requires awareness of DIL-inducing potential of chronic medication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045386

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  1 in total

1.  MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.

Authors:  Estefania Ugarte-Berzal; Lise Boon; Erik Martens; Vasily Rybakin; Daniel Blockmans; Jennifer Vandooren; Paul Proost; Ghislain Opdenakker
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.